Pharmaceuticals - , Pennsylvania, United States
Qrono Inc is a specialty pharma company with a research, funded cancer therapy platform focused on helping the 80% of patients without an effective treatment option. QARRUS®, our platform, targets chemotherapy to cancer stem cells and tumor associated macrophages, disrupting tumor growth and metastasis. Qrono has demonstrated proof-of-concept for its lead product, a QARRUS-epothilone therapy (QR206), in two head and neck cancer (HNC) models. QR206 is progressing through IND-enabling studies that will culminate in a feline HNC veterinary trial. Qrono is actively seeking partners and investors to support the clinical translation of QR206 for patients with multirefractory HNC.
Gmail
Varnish
Wix
Mobile Friendly
Google Cloud Hosting